Keywords: Avastin, Lucentis, Novartis, Roche, Macular degeneration, AMD

Avastin and Lucentis equivalent in treating age-related macular degeneration

Article | 02 May 2012

Print This

At two years, the cancer drug Avastin (bevacizumab) and the ophthalmic agent Lucentis (ranibizumab injection), both of which are widely ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in